Ou Bai, Md/phd
Clinical trials sponsored by Ou Bai, Md/phd, explained in plain language.
-
New drug could keep lymphoma at bay in hepatitis b patients
Disease control Recruiting nowThis Phase 3 trial is testing whether the drug chidamide can help prevent diffuse large B-cell lymphoma from returning in patients who also have hepatitis B. Participants must have achieved complete remission after initial chemotherapy (R-CHOP). They will take chidamide twice a w…
Phase: PHASE3 • Sponsor: Ou Bai, MD/PHD • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for elderly lymphoma patients: targeted combo aims to control aggressive cancer
Disease control Recruiting nowThis study tests a new drug combination for people aged 70 and older with a fast-growing type of lymphoma called double-expressor DLBCL. Participants receive chidamide pills plus a reduced-strength chemotherapy regimen, followed by maintenance therapy with chidamide and a targete…
Phase: PHASE2 • Sponsor: Ou Bai, MD/PHD • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC